institut pasteur de lille based in Lille, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-07-18

US20240238244A1

Human necessities

USE OF A COMPOUND SUCH AS PLERIXAFOR FOR TREATING A VIRAL PULMONARY DISEASE

#2 | 2023-05-25

US20230157994A1

Human necessities

NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE

#3 | 2023-01-05 ✅ Patent 12,460,009 granted on 2025-11-04

US20230002497A1

Chemistry; metallurgy

ANTIBODIES SPECIFIC FOR IL20-RB AND USES THEREOF FOR THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#4 | 2022-03-03 ✅ Patent 12,539,312 granted on 2026-02-03

US20220062326A1

Human necessities

USE OF MATERIALS MADE OF CROSS-LINKED BETA-CYCLODEXTRINS FOR THE TREATMENT OF TUBERCULOSIS

#5 | 2022-02-03 ✅ Patent 12,473,357 granted on 2025-11-18

US20220033486A1

Chemistry; metallurgy

USE OF ANTAGONISTS OF TH17 CYTOKINES FOR THE TREATMENT OF BRONCHIAL REMODELING IN PATIENTS SUFFERING FROM ALLERGIC ASTHMA

#6 | 2020-12-17 ✅ Patent 11,364,219 granted on 2022-06-21

US20200390740A1

Human necessities

Methods and pharmaceutical compositions for treating microbiome dysregulations associated with circadian clock disruption

#7 | 2020-09-24 ✅ Patent 11,446,372 granted on 2022-09-20

US20200297833A1

Human necessities

strains expressing serotype 3 fimbriae

#8 | 2020-07-09 ✅ Patent 11,926,664 granted on 2024-03-12

US20200216530A1

Chemistry; metallurgy

Methods and pharmaceutical compositions for modulating monocytopoiesis

#9 | 2019-11-21 ✅ Patent 10,875,896 granted on 2020-12-29

US20190352342A1

Chemistry; metallurgy

Hepatitis E virus ORF2 capsid polypeptides and uses thereof

#10 | 2019-10-31 ✅ Patent 12,358,977 granted on 2025-07-15

US20190330330A1

Chemistry; metallurgy

TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20R

#11 | 2019-05-30 ✅ Patent 11,226,343 granted on 2022-01-18

US20190162736A1

Physics

Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery

#12 | 2018-11-29 ✅ Patent 10,369,207 granted on 2019-08-06

US20180339035A1

Human necessities

Prevention of pertussis using adenylate cyclase deficient Bordetella strains

#13 | 2018-09-20 ✅ Patent 10,736,937 granted on 2020-08-11

US20180264077A1

Human necessities

Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza

#14 | 2018-05-31 ✅ Patent 10,265,302 granted on 2019-04-23

US20180147191A1

Human necessities

Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound

#15 | 2018-03-29 ✅ Patent 10,420,827 granted on 2019-09-24

US20180085450A1

Human necessities

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

#16 | 2017-12-28 ✅ Patent 10,435,450 granted on 2019-10-08

US20170369545A1

Chemistry; metallurgy

MET receptor agonist proteins

#17 | 2017-07-27 ✅ Patent 9,932,309 granted on 2018-04-03

US20170210710A1

Chemistry; metallurgy

2-oxo-3,4-dihydropyridine-5-carboxylates and their use

#18 | 2017-07-20 ✅ Patent 10,046,044 granted on 2018-08-14

US20170202944A1

Human necessities

Prevention of using adenylate cyclase deficient strains

#19 | 2017-07-06 ✅ Patent 10,323,016 granted on 2019-06-18

US20170190687A1

Chemistry; metallurgy

Imidazol- or 1,2,4-triazol-derivatives and their use

#20 | 2017-01-26 ✅ Patent 9,956,284 granted on 2018-05-01

US20170021015A1

Human necessities

Immunoadjuvant flagellin-based compounds and use thereof

#21 | 2016-06-02 ✅ Patent 9,919,029 granted on 2018-03-20

US20160151453A1

Human necessities

Methods and pharmaceutical compositions for the treatment of bacterial infections

#22 | 2016-04-07 ✅ Patent 9,655,959 granted on 2017-05-23

US20160095914A1

Human necessities

Adenylate cyclase deficient bordetella strains

#23 | 2015-08-13

US20150224129A1

Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA WITH INVARIANT NKT CELL AGONISTS

#24 | 2015-07-30 ✅ Patent 9,528,086 granted on 2016-12-27

US20150210978A1

Chemistry; metallurgy

Recombinant strains

#25 | 2015-07-02 ✅ Patent 9,839,683 granted on 2017-12-12

US20150182614A1

Human necessities

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

#26 | 2015-02-12 ✅ Patent 9,796,758 granted on 2017-10-24

US20150045506A1

Chemistry; metallurgy

Native ligation process

#27 | 2014-07-24 ✅ Patent 10,426,816 granted on 2019-10-01

US20140206601A1

Human necessities

Methods and pharmaceutical compositions for the treatment of respiratory tract infections

#28 | 2013-08-22 ✅ Patent 9,913,829 granted on 2018-03-13

US20130217717A1

Human necessities

Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound

#29 | 2013-07-18 ✅ Patent 8,986,709 granted on 2015-03-24

US20130183336A1

Human necessities

Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

#30 | 2012-08-30 ✅ Patent 9,029,503 granted on 2015-05-12

US20120220721A1

Chemistry; metallurgy

Method for native ligation of polypeptides

#31 | 2012-07-12

US20120177688A1

Human necessities

Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology

#32 | 2012-05-17 ✅ Patent 9,526,778 granted on 2016-12-27

US20120121647A1

Human necessities

Influenza vaccine, composition, and methods of use

#33 | 2012-05-15 ✅ Patent 8,178,474 granted on 2012-05-15

US10196900

Functionalised solid support for alpha-oxoaldehyde synthesis

#34 | 2012-04-12 ✅ Patent 8,986,936 granted on 2015-03-24

US20120088259A1

Physics

Post-translation modified cardiac troponin T as a biomarker of a risk for heart failure

#35 | 2012-01-19

US20120015387A1

Physics

MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT

#36 | 2011-12-08

US20110301092A1

Human necessities

THE USE OF A NON-GLYCANATED POLYPEPTIDE FOR TREATING A CANCER

#37 | 2011-06-09 ✅ Patent 8,338,599 granted on 2012-12-25

US20110136823A1

Chemistry; metallurgy

Compounds having a potentiating effect on the activity of ethionamide and uses thereof

#38 | 2011-05-12 ✅ Patent 9,527,891 granted on 2016-12-27

US20110110962A1

Human necessities

Immunoadjuvant flagellin-based compounds and use thereof

#39 | 2010-02-09 ✅ Patent 7,659,055 granted on 2010-02-09

US10086206

Fragments of nucleic acids specific to mycobacteria which are members of the complex and their applications for the detection and the differential diagnosis of members of the complex

#40 | 2007-12-11 ✅ Patent 7,306,797 granted on 2007-12-11

US10416203

Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer

#41 | 2005-09-27 ✅ Patent 6,949,345 granted on 2005-09-27

US9192579

Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin

Also check out INSTITUT PASTEUR DE LILLE's (Lille, France) applicant profile with 43 patent applications submitted.

AssigneeID:

36057 ⎘